13. Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details
Clinical trials : 3,340 / Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04787497 (ClinicalTrials.gov) | December 2021 | 1/3/2021 | The Effect of Extra Virgin Olive Oil in People With Multiple Sclerosis | The Neuropsychological Effects of Extra-Virgin Olive Oil in People With Multiple Sclerosis | Multiple Sclerosis | Dietary Supplement: High Phenolic Extra Virgin Olive Oil | University of Cyprus | World Olive Center for Health;Ellis-Farm, Eliama Daily Value | Not yet recruiting | 18 Years | 65 Years | All | 100 | N/A | NULL |
2 | NCT04120675 (ClinicalTrials.gov) | November 9, 2018 | 24/9/2019 | Efficacy of Early Harvest Olive Oil in Cognition of Primary (PPMS) or Secondary (SPMS) Progressive Multiple Sclerosis | The Effects of Early Harvest Extra Virgin Olive Oil on Cognition and Mental Health of Primary (PPMS) or Secondary (SPMS) Progressive Multiple Sclerosis Patients | Progressive Multiple Sclerosis | Dietary Supplement: Early Harvest Extra Virgin Olive Oil | Aristotle University Of Thessaloniki | Greek Alzheimer's Association and Related Disorders;Ellis-Farm, Eliama Daily Value Gold (ellis-farm.com) | Completed | 18 Years | 65 Years | All | 30 | N/A | Greece |